These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 9715282
21. Plexiform-like neurofibromas develop in the mouse by intraneural xenograft of an NF1 tumor-derived Schwann cell line. Perrin GQ, Fishbein L, Thomson SA, Thomas SL, Stephens K, Garbern JY, DeVries GH, Yachnis AT, Wallace MR, Muir D. J Neurosci Res; 2007 May 01; 85(6):1347-57. PubMed ID: 17335073 [Abstract] [Full Text] [Related]
22. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells. Munchhof AM, Li F, White HA, Mead LE, Krier TR, Fenoglio A, Li X, Yuan J, Yang FC, Ingram DA. Hum Mol Genet; 2006 Jun 01; 15(11):1858-69. PubMed ID: 16648142 [Abstract] [Full Text] [Related]
23. Regulated expression of neurofibromin in migrating neural crest cells of avian embryos. Stocker KM, Baizer L, Coston T, Sherman L, Ciment G. J Neurobiol; 1995 Aug 01; 27(4):535-52. PubMed ID: 7561832 [Abstract] [Full Text] [Related]
24. c-Kit receptor expression in normal human Schwann cells and Schwann cell lines derived from neurofibromatosis type 1 tumors. Dang I, Nelson JK, DeVries GH. J Neurosci Res; 2005 Nov 15; 82(4):465-71. PubMed ID: 16235251 [Abstract] [Full Text] [Related]
25. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1. Barkan B, Starinsky S, Friedman E, Stein R, Kloog Y. Clin Cancer Res; 2006 Sep 15; 12(18):5533-42. PubMed ID: 17000690 [Abstract] [Full Text] [Related]
26. CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene. Sherman L, Jacoby LB, Lampe J, Pelton P, Aguzzi A, Herrlich P, Ponta H. Cancer Res; 1997 Nov 01; 57(21):4889-97. PubMed ID: 9354454 [Abstract] [Full Text] [Related]
27. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. Dasgupta B, Yi Y, Hegedus B, Weber JD, Gutmann DH. Cancer Res; 2005 Nov 01; 65(21):9843-50. PubMed ID: 16267007 [Abstract] [Full Text] [Related]
28. Modulation of neurofibromatosis type 1 gene expression during in vitro myoblast differentiation. Gutmann DH, Cole JL, Collins FS. J Neurosci Res; 1994 Feb 15; 37(3):398-405. PubMed ID: 8176761 [Abstract] [Full Text] [Related]
29. Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients. Rosenbaum C, Kluwe L, Mautner VF, Friedrich RE, Müller HW, Hanemann CO. Neurobiol Dis; 1998 Jul 15; 5(1):55-64. PubMed ID: 9702788 [Abstract] [Full Text] [Related]
30. Schwann cell preparation from single mouse embryos: analyses of neurofibromin function in Schwann cells. Ratner N, Williams JP, Kordich JJ, Kim HA. Methods Enzymol; 2006 Jul 15; 407():22-33. PubMed ID: 16757311 [Abstract] [Full Text] [Related]
31. Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1. Mashour GA, Driever PH, Hartmann M, Drissel SN, Zhang T, Scharf B, Felderhoff-Müser U, Sakuma S, Friedrich RE, Martuza RL, Mautner VF, Kurtz A. Clin Cancer Res; 2004 Sep 01; 10(17):5677-83. PubMed ID: 15355893 [Abstract] [Full Text] [Related]
32. Impaired intercellular adhesion and immature adherens junctions in merlin-deficient human primary schwannoma cells. Flaiz C, Utermark T, Parkinson DB, Poetsch A, Hanemann CO. Glia; 2008 Apr 01; 56(5):506-15. PubMed ID: 18240308 [Abstract] [Full Text] [Related]
33. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras. Gutmann DH, Giordano MJ, Mahadeo DK, Lau N, Silbergeld D, Guha A. Oncogene; 1996 May 16; 12(10):2121-7. PubMed ID: 8668337 [Abstract] [Full Text] [Related]
34. Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone. Overdiek A, Winner U, Mayatepek E, Rosenbaum T. Pediatr Res; 2008 Jul 16; 64(1):40-3. PubMed ID: 18360307 [Abstract] [Full Text] [Related]
35. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response. Xu J, Ismat FA, Wang T, Yang J, Epstein JA. Circulation; 2007 Nov 06; 116(19):2148-56. PubMed ID: 17967772 [Abstract] [Full Text] [Related]
36. Nucleophosmin mediates mammalian target of rapamycin-dependent actin cytoskeleton dynamics and proliferation in neurofibromin-deficient astrocytes. Sandsmark DK, Zhang H, Hegedus B, Pelletier CL, Weber JD, Gutmann DH. Cancer Res; 2007 May 15; 67(10):4790-9. PubMed ID: 17510408 [Abstract] [Full Text] [Related]
37. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging. Su W, Xing R, Guha A, Gutmann DH, Sherman LS. Glia; 2007 May 15; 55(7):723-33. PubMed ID: 17348023 [Abstract] [Full Text] [Related]
38. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors. Wallace MR, Rasmussen SA, Lim IT, Gray BA, Zori RT, Muir D. Genes Chromosomes Cancer; 2000 Feb 15; 27(2):117-23. PubMed ID: 10612798 [Abstract] [Full Text] [Related]
39. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Guha A, Lau N, Huvar I, Gutmann D, Provias J, Pawson T, Boss G. Oncogene; 1996 Feb 01; 12(3):507-13. PubMed ID: 8637706 [Abstract] [Full Text] [Related]
40. Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase. Kim HA, Ling B, Ratner N. Mol Cell Biol; 1997 Feb 01; 17(2):862-72. PubMed ID: 9001241 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]